Johnson & Johnson JNJ
Valuation
Multiples measured against the stock's own five-year history
Near the top of its 5-year range · 100th percentile, 5-year average 22.2x
#2424 of 2972 stocks by PE (1 = cheapest)
Near the top of its 5-year range · 100th percentile, 5-year average 5.9x
#4778 of 5311 stocks by PB (1 = cheapest)
Near the top of its 5-year range · 98th percentile, 5-year average 4.8x
#4174 of 5150 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 8.07 | – | 5.89 | 100% (pricier than usual) | #4778 of 5311 (1 = cheapest) |
| PE | 41.52 | 27.38 | 22.20 | 100% (pricier than usual) | #2424 of 2972 (1 = cheapest) |
| PS | 6.62 | 6.22 | 4.77 | 98% (pricier than usual) | #4174 of 5150 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on JNJ.
Sign in to join the discussion.